Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-ichi Hanada

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|January 25, 2011
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinomaQiong J Wang, Ken-ichi Hanada, Steven A Feldman, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing CancersQiong J Wang, Zhiya Yu, Ken-Ichi Hanada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsTakashi Inozume, Ken-Ichi Hanada, Qiong J Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumorQiong J Wang, Ken-ichi Hanada, Donna Perry-Lalley, et al.
Journal for Immunotherapy of Cancer|September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomicsCatherine M Ade, Matthew J Sporn, Sudipto Das, et al.
European Journal of Immunology|July 20, 2024
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3Malcolm J W Sim, Ken-Ichi Hanada, Zachary Stotz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2023
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigensAnup Y Parikh, Robert Masi, Billel Gasmi, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|January 25, 2011
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinomaQiong J Wang, Ken-ichi Hanada, Steven A Feldman, et al.
Cancer Immunology Research|December 25, 2015
Identification of T-cell Receptors Targeting KRAS-Mutated Human TumorsQiong J Wang, Zhiya Yu, Kayla Griffith, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2016
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing CancersQiong J Wang, Zhiya Yu, Ken-Ichi Hanada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cellsTakashi Inozume, Ken-Ichi Hanada, Qiong J Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2005
Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumorQiong J Wang, Ken-ichi Hanada, Donna Perry-Lalley, et al.
Journal for Immunotherapy of Cancer|September 27, 2023
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomicsCatherine M Ade, Matthew J Sporn, Sudipto Das, et al.
European Journal of Immunology|July 20, 2024
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3Malcolm J W Sim, Ken-Ichi Hanada, Zachary Stotz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2023
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigensAnup Y Parikh, Robert Masi, Billel Gasmi, et al.
Pageof 4